Latest Publications
Explore our most recent scientific milestones, peer-reviewed insights, and the impact Unicorn Biotechnologies is making in the life sciences space.
Alternatives to Knee Replacement Surgery: The Multi-Modal Treatment Protocol That Achieves 90% Surgical Avoidance
Studies show 80% of patients told they need knee replacement may not actually require surgery. Multi-modal cellular therapy protocols now help over 90% of patients avoid knee replacement entirely, offering a compelling alternative to traditional surgical approaches.
Do I Really Need Knee Replacement Surgery? The 66% Appropriateness Question Your Doctor Should Answer
Research reveals that approximately 34% of knee replacement surgeries may be inappropriate based on validated medical criteria. This article explains the evidence-based appropriateness framework that helps patients have informed conversations with their doctors about whether they truly need knee replacement surgery.
PRP Injection with Ultrasound Guidance: The 96% Accuracy Standard That Protects Your Investment
Ultrasound-guided PRP injections achieve 96% accuracy compared to 83.7% with palpation alone—a critical difference that determines treatment success. Learn why precision placement protects your investment and why imaging guidance has become the standard of care for platelet-rich plasma therapy.
Stem Cell Therapy Boca Raton Florida: Why SB 1768 Changes Everything for Local Patients
Florida's SB 1768 legislation has revolutionized stem cell therapy access in Boca Raton, creating regulated pathways for orthopedic, wound care, and pain management treatments. Learn how this 2025 law positions local patients to access cutting-edge regenerative medicine without the risks of medical tourism.
Regenerative Medicine Consultation Online: Your Complete Virtual-to-Treatment Roadmap 2026
Discover how regenerative medicine consultation online works in 2026, from your first virtual appointment to actual treatment. This comprehensive guide reveals the complete virtual-to-treatment process, required documentation, realistic timelines, and what you can—and can't—accomplish remotely.
Stem Cell Therapy for Knee Pain 2026: What the $140M Clinical Trial Means for Patients
MEDIPOST's $140 million Phase III clinical trial is advancing stem cell therapy for knee pain in 2026, marking a pivotal moment in regenerative medicine. This comprehensive guide explains what the trial means for patients seeking alternatives to knee replacement surgery and how to make informed treatment decisions.





